Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phaseQi Xiong, Yi Hu, Bo Yang et al.|Cancer Immunology Immunotherapy|2020Cited by 73